Both in Pharmaceuticals
CorMedix vs Gyre Therapeutics
Over the past year CRMD returned −50.4% and GYRE returned −38.8%; their daily moves had a correlation of 0.36.
CRMD −50.4% GYRE −38.8%Growth of $1, one year, split-adjusted
| Metric | CRMD | GYRE |
|---|---|---|
| Price | $5.66 | $4.44 |
| Market cap | $441.2M | $470.8M |
| Today | +1.80% | 0.00% |
| 1 month | −22.3% | −37.3% |
| 6 months | −29.7% | −44.8% |
| Year to date | −51.3% | −37.1% |
| 1 year | −51.0% | −39.7% |
| Revenue growth (YoY) | +156.5% | −2.1% |
| Gross margin | 75.7% | 92.4% |
| Net margin | 25.5% | −40.1% |
| P/E (TTM) | 2.4× | — |
| Price / sales | 1.0× | 3.9× |
| Net cash | $256.7M | $74.8M |
| Dividend yield | — | — |
| Volatility (60d) | 77.3% | 88.3% |
| Short % of float | 20.8% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).